We are live on ! Find out more
ANEB

Anebulo Pharmaceuticals

Delisted

ANEB was delisted on the 27th of February, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
2L
1
22NW LP
Washington
$84.8M
NCM
2
Nantahala Capital Management
Connecticut
$3.07M
MP
3
Mangrove Partners
Connecticut
$2.55M
Vanguard Group
4
Vanguard Group
Pennsylvania
$440K +$295K +129,281 +42%
Morgan Stanley
5
Morgan Stanley
New York
$403K
Geode Capital Management
6
Geode Capital Management
Massachusetts
$162K -$30.5K -13,348 -8%
RC
7
Rangeley Capital
Connecticut
$50.5K +$68.5K +30,000 +150%
Renaissance Technologies
8
Renaissance Technologies
New York
$25.3K -$7.76K -3,402 -12%
Citadel Advisors
9
Citadel Advisors
Florida
$24.5K +$55.3K +24,239 New
BlackRock
10
BlackRock
New York
$24K -$616 -270 -1%
Northern Trust
11
Northern Trust
Illinois
$22.2K -$5.47K -2,399 -10%
IC
12
Ikarian Capital
Texas
$17.9K -$319K -139,984 -89%
State Street
13
State Street
Massachusetts
$12.9K
TRCT
14
Tower Research Capital (TRC)
New York
$3.26K +$3.38K +1,480 +85%
UBS Group
15
UBS Group
Switzerland
$2.36K +$4.82K +2,114 +961%
JP Morgan Chase
16
JP Morgan Chase
New York
$2.28K +$262 +115 +5%
Bank of America
17
Bank of America
North Carolina
$386 -$1.16K -509 -57%
XT
18
XTX Topco
Cayman Islands
-$47.9K -19,153 Closed
BFM
19
Boothbay Fund Management
New York
-$47.1K -18,836 Closed
Barclays
20
Barclays
United Kingdom
-$998 -399 Closed
Citigroup
21
Citigroup
New York
-$15 -6 Closed
FIA
22
FNY Investment Advisers
New York
+$11 +5 +5%
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
+$68 +30 New